Elevated serum concentrations of the angiogenesis inhibitor endostatin in preeclamptic women. 2003

Kora Hirtenlehner, and Jürgen Pollheimer, and Cornelia Lichtenberger, and Markus F Wolschek, and Harald Zeisler, and Peter Husslein, and Martin Knöfler
Departments of Obstetrics and Gynecology, University of Vienna,Vienna, Austria.

OBJECTIVE Changes in serum levels of angiogenic factors such as vascular endothelial growth factor or placental growth factor were associated with preeclampsia. The aim of our study was to investigate the concentrations of endostatin, a potent endogenous inhibitor of angiogenesis and endothelial or tumor cell growth, in preeclamptic patients. METHODS Levels of soluble endostatin were determined by enzyme-linked immunosorbent assay and Western blot analysis in sera of nonpregnant women, healthy pregnant women, and patients with different forms of preeclampsia. RESULTS Statistical analyses of age-matched study groups revealed elevated medians of endostatin concentration for severely (30.5 ng/mL) and mildly (26.05 ng/mL) preeclamptic patients compared with healthy pregnant (17.2 ng/mL) and nonpregnant women (17.2 ng/mL). Western blot analysis confirmed the up-regulation of soluble endostatin molecules (24 kD) in sera of severely preeclamptic patients. CONCLUSIONS Elevated concentrations of endostatin could play a role in the pathophysiology of preeclampsia by counteracting the effects of vascular endothelial growth factor. The inhibitor could also be responsible for the observed growth-inhibitory effects of preeclamptic plasma on endothelial cells.

UI MeSH Term Description Entries
D011225 Pre-Eclampsia A complication of PREGNANCY, characterized by a complex of symptoms including maternal HYPERTENSION and PROTEINURIA with or without pathological EDEMA. Symptoms may range between mild and severe. Pre-eclampsia usually occurs after the 20th week of gestation, but may develop before this time in the presence of trophoblastic disease. Toxemias, Pregnancy,EPH Complex,EPH Gestosis,EPH Toxemias,Edema-Proteinuria-Hypertension Gestosis,Gestosis, EPH,Hypertension-Edema-Proteinuria Gestosis,Preeclampsia,Preeclampsia Eclampsia 1,Pregnancy Toxemias,Proteinuria-Edema-Hypertension Gestosis,Toxemia Of Pregnancy,1, Preeclampsia Eclampsia,1s, Preeclampsia Eclampsia,EPH Toxemia,Eclampsia 1, Preeclampsia,Eclampsia 1s, Preeclampsia,Edema Proteinuria Hypertension Gestosis,Gestosis, Edema-Proteinuria-Hypertension,Gestosis, Hypertension-Edema-Proteinuria,Gestosis, Proteinuria-Edema-Hypertension,Hypertension Edema Proteinuria Gestosis,Of Pregnancies, Toxemia,Of Pregnancy, Toxemia,Pre Eclampsia,Preeclampsia Eclampsia 1s,Pregnancies, Toxemia Of,Pregnancy Toxemia,Pregnancy, Toxemia Of,Proteinuria Edema Hypertension Gestosis,Toxemia Of Pregnancies,Toxemia, EPH,Toxemia, Pregnancy,Toxemias, EPH
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D012016 Reference Values The range or frequency distribution of a measurement in a population (of organisms, organs or things) that has not been selected for the presence of disease or abnormality. Normal Range,Normal Values,Reference Ranges,Normal Ranges,Normal Value,Range, Normal,Range, Reference,Ranges, Normal,Ranges, Reference,Reference Range,Reference Value,Value, Normal,Value, Reference,Values, Normal,Values, Reference
D004797 Enzyme-Linked Immunosorbent Assay An immunoassay utilizing an antibody labeled with an enzyme marker such as horseradish peroxidase. While either the enzyme or the antibody is bound to an immunosorbent substrate, they both retain their biologic activity; the change in enzyme activity as a result of the enzyme-antibody-antigen reaction is proportional to the concentration of the antigen and can be measured spectrophotometrically or with the naked eye. Many variations of the method have been developed. ELISA,Assay, Enzyme-Linked Immunosorbent,Assays, Enzyme-Linked Immunosorbent,Enzyme Linked Immunosorbent Assay,Enzyme-Linked Immunosorbent Assays,Immunosorbent Assay, Enzyme-Linked,Immunosorbent Assays, Enzyme-Linked
D005260 Female Females
D005865 Gestational Age The age of the conceptus, beginning from the time of FERTILIZATION. In clinical obstetrics, the gestational age is often estimated from the onset of the last MENSTRUATION which is about 2 weeks before OVULATION and fertilization. It is also estimated to begin from fertilization, estrus, coitus, or artificial insemination. Embryologic Age,Fetal Maturity, Chronologic,Chronologic Fetal Maturity,Fetal Age,Maturity, Chronologic Fetal,Age, Embryologic,Age, Fetal,Age, Gestational,Ages, Embryologic,Ages, Fetal,Ages, Gestational,Embryologic Ages,Fetal Ages,Gestational Ages
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D015153 Blotting, Western Identification of proteins or peptides that have been electrophoretically separated by blot transferring from the electrophoresis gel to strips of nitrocellulose paper, followed by labeling with antibody probes. Immunoblotting, Western,Western Blotting,Western Immunoblotting,Blot, Western,Immunoblot, Western,Western Blot,Western Immunoblot,Blots, Western,Blottings, Western,Immunoblots, Western,Immunoblottings, Western,Western Blots,Western Blottings,Western Immunoblots,Western Immunoblottings
D016015 Logistic Models Statistical models which describe the relationship between a qualitative dependent variable (that is, one which can take only certain discrete values, such as the presence or absence of a disease) and an independent variable. A common application is in epidemiology for estimating an individual's risk (probability of a disease) as a function of a given risk factor. Logistic Regression,Logit Models,Models, Logistic,Logistic Model,Logistic Regressions,Logit Model,Model, Logistic,Model, Logit,Models, Logit,Regression, Logistic,Regressions, Logistic

Related Publications

Kora Hirtenlehner, and Jürgen Pollheimer, and Cornelia Lichtenberger, and Markus F Wolschek, and Harald Zeisler, and Peter Husslein, and Martin Knöfler
April 2000, Arthritis and rheumatism,
Kora Hirtenlehner, and Jürgen Pollheimer, and Cornelia Lichtenberger, and Markus F Wolschek, and Harald Zeisler, and Peter Husslein, and Martin Knöfler
March 2003, Wiener klinische Wochenschrift,
Kora Hirtenlehner, and Jürgen Pollheimer, and Cornelia Lichtenberger, and Markus F Wolschek, and Harald Zeisler, and Peter Husslein, and Martin Knöfler
January 2003, Leukemia research,
Kora Hirtenlehner, and Jürgen Pollheimer, and Cornelia Lichtenberger, and Markus F Wolschek, and Harald Zeisler, and Peter Husslein, and Martin Knöfler
January 2002, Journal of atherosclerosis and thrombosis,
Kora Hirtenlehner, and Jürgen Pollheimer, and Cornelia Lichtenberger, and Markus F Wolschek, and Harald Zeisler, and Peter Husslein, and Martin Knöfler
January 1997, Cell,
Kora Hirtenlehner, and Jürgen Pollheimer, and Cornelia Lichtenberger, and Markus F Wolschek, and Harald Zeisler, and Peter Husslein, and Martin Knöfler
September 2004, International journal of colorectal disease,
Kora Hirtenlehner, and Jürgen Pollheimer, and Cornelia Lichtenberger, and Markus F Wolschek, and Harald Zeisler, and Peter Husslein, and Martin Knöfler
February 2008, Lung cancer (Amsterdam, Netherlands),
Kora Hirtenlehner, and Jürgen Pollheimer, and Cornelia Lichtenberger, and Markus F Wolschek, and Harald Zeisler, and Peter Husslein, and Martin Knöfler
March 1998, The EMBO journal,
Kora Hirtenlehner, and Jürgen Pollheimer, and Cornelia Lichtenberger, and Markus F Wolschek, and Harald Zeisler, and Peter Husslein, and Martin Knöfler
July 1999, Gynecologic oncology,
Kora Hirtenlehner, and Jürgen Pollheimer, and Cornelia Lichtenberger, and Markus F Wolschek, and Harald Zeisler, and Peter Husslein, and Martin Knöfler
November 1993, The New England journal of medicine,
Copied contents to your clipboard!